Back to search

University of Birmingham

Biomarkers predict outcomes in patients with atrial fibrillation and cardiovascular conditions

Abstract

dc:description.abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with a prevalence of 3-4%. Thirteen cardiovascular biomarkers selected in a Delphi process were centrally quantified on high-precision, high-throughput analysers (Roche Diagnostics, Penzberg, Germany) in 1620 patients recruited into Birmingham Black Country Atrial Fibrillation Registry at Sandwell and West Birmingham NHS Trust. Follow-up information on outcomes (cardiovascular death, heart failure hospitalization, stroke or systemic embolism and acute coronary syndrome) were obtained using health records and central mortality data from NHS digital. Follow-up was for a median of 4.2 (IQR 3.5–4.9) years with analysis performed at 2.5 years. Clinical characteristics and biomarker concentrations were related to outcomes. Study 1 examines the value of NT-proBNP in predicting cardiovascular death or heart failure hospitalization in phenotype groups based on AF and heart failure status. Study 2 examines biomarker predictors and clinical predictors of major adverse cardiovascular events (MACE) in patients with cardiovascular conditions.

Degree

thesis:*
Name dc:type.qualificationname
h_md
Level dc:type.qualificationlevel
h_md
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Brady, Paul

Subjects

dc:subject × 2

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Brady, Paul. Biomarkers predict outcomes in patients with atrial fibrillation and cardiovascular conditions. h_md thesis, University of Birmingham, 2022.